ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hypertension Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,302Medicare Part D Prescriptions Filled, Including Refills
$242K Total Retail Price of All Prescriptions
287 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LOVASTATIN 332 244
AMLODIPINE BESYLATE 276 190
LISINOPRIL 271 179
METFORMIN HCL 241 172
FUROSEMIDE 222 154
HYDROCODONE-ACETAMINOPHEN 205 111 S3
OMEPRAZOLE 194 136
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 78
DOXAZOSIN MESYLATE 146 95
POTASSIUM CHLORIDE 131 84
CARVEDILOL 117 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 66
MELOXICAM 95 52
GABAPENTIN 94 35
CLONIDINE HCL 84 51
SPIRONOLACTONE 82 69
AMOXICILLIN 79 56
LEVOTHYROXINE SODIUM 79 62
HYDROCHLOROTHIAZIDE 76 48
BYSTOLIC 66 54
AMLODIPINE BESYLATE-BENAZEPRIL 64 56
NAPROXEN 63 28
WARFARIN SODIUM 62 62
SIMVASTATIN 61 39
KLOR-CON M20 57 39
PREDNISONE 57 41
ATORVASTATIN CALCIUM 55 37
CLOPIDOGREL 54 40
ZOLPIDEM TARTRATE 53 21
FLUOXETINE HCL 51 12
DONEPEZIL HCL 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.